GenSight Biologics
Develops innovative therapies for mitochondrial and neurodegenerative diseases
Total raised
€88M
€87,727,272
Funding rounds
4
Investors
6
distinct backers
Active since
2013-03
latest 2025-07
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood30
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 15y since founding
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-18 | Other | €500k | undisclosed investors | View deal → |
| 2017-09-14 | Other | €23M | — | View deal → |
| 2015-07-01 | Series B | €33M | Abingworth LLP,Fidelity,HealthCap,Index Ventures,Novartis Venture Fund | View deal → |
| 2013-04-01 | Series A | €32M | Abingworth LLP,Index Ventures,Novartis Venture Fund | View deal → |
Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software